It's OK to use nasal spray flu vaccine again, US panel says

February 21, 2018 by Mike Stobbe
It's OK to use nasal spray flu vaccine again, US panel says
In this Oct. 4, 2005 file photo, Amanda Klopfer reacts as she is given a FluMist influenza vaccination in St. Leonard, Md. On Wednesday, Feb. 21, 2018, a federal panel says it's OK for doctors to start using the kid-friendly nasal spray flu vaccine again. (AP Photo/Chris Gardner, File)

It's OK for doctors to start using a kid-friendly nasal spray flu vaccine again, a federal panel said Wednesday.

Two years ago, the advisory group pulled its recommendation for FluMist vaccine after research found it wasn't working against swine flu, the kind of flu that was making most people sick then. But the Advisory Committee of Immunization Practices voted 12-2 Wednesday to recommend the as an option for next winter's flu season.

An official from AstraZeneca, the company that makes FluMist, said the problem with the vaccine has been identified and corrected. But panel members noted there's still not good proof that FluMist works well against the swine flu bug.

"This is not an easy decision. It's always a challenge to make a decision with incomplete data," said one panel member, Dr. Edward Belongia of the Wisconsin-based Marshfield Clinic Research Foundation.

The panel makes its recommendations to the Centers for Disease Control and Prevention, which usually accepts the advice and sends it along as guidance to doctors, hospitals and health insurers.

FluMist is the only spray-in-the-nose vaccine on the market. It was first licensed in 2003 and is approved for healthy people ages 2 to 49. Unlike shots made from a killed virus, it is made from a live but weakened .

The AstraZeneca product was once considered the best childhood flu vaccine on the market and accounted for about a third of all child vaccinations. But in 2016, the committee rescinded its recommendation of FluMist after federal study results showed it provided no protection from the 2009 swine flu strain that made most people sick the previous year. It remained on the market, but for the past two winters federal officials have not been recommending that doctors give it.

AstraZeneca has changed the way it tests and selects strains for the , said Dr. Raburn Mallory, a company official, speaking at the panel meeting in Atlanta. It's been difficult for researchers to check how well the revised product works, in part because in the last two years another type of flu—not swine flu—has caused most of each season's illnesses.

Studies have suggested that while FluMist fell down against swine flu, it has been effective against other types of flu.

That makes it better than nothing, panel members said. And FluMist is appealing because it is easier to give to kids who fear needles.

Some experts at the meeting worried the panel's decision could further damage public confidence in flu vaccines. If FluMist should fail to protect children during a bad in the future, "that's a potential disaster," said Dr. Sean O'Leary of the Pediatric infectious Diseases Society.

Last week, a government study found the was doing a poor job this winter. The changes from year to year, depending on what flu bugs are going around.

Explore further: Heat blamed for spray vaccine's failure against swine flu

Related Stories

Heat blamed for spray vaccine's failure against swine flu

February 26, 2015
(AP)—The makers of the nasal spray version of the flu vaccine say now they know why it has failed to protect young U.S. children against swine flu—fragile doses got too warm.

Ouch! Flu spray fails again, panel urges shot instead

June 22, 2016
The nasal spray version of the annual flu vaccine failed to protect kids again last year, the latest in a string of failures that has prompted an expert panel to recommend that doctors stop giving it to patients.

Panel: Flu spray better than shots for young kids

June 25, 2014
When it comes to flu vaccines, a federal panel says a squirt in the nose is better than a shot in the arm for young children.

Vaccine spray may not work for swine flu in kids

November 6, 2014
Health officials say the nasal spray version of the flu vaccine did not protect young children against swine flu last winter and might not work again this year.

CDC says flu nasal spray vaccine doesn't work

July 4, 2016
The Centers for Disease Control and Prevention says the flu nasal spray vaccine (FluMist) should not be used for the 2016-17 flu season because it doesn't work. The CDC also recommends that everyone over 6 months of age get ...

Recommended for you

Sick air travelers mostly likely to infect next row: study

March 19, 2018
People who fly on airplanes while contagious can indeed get other people sick, but the risk is mainly to those seated next to them or in the adjacent row, US researchers said Monday.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...

Newly described human antibody prevents malaria in mice

March 19, 2018
Scientists have discovered a human antibody that protected mice from infection with the deadliest malaria parasite, Plasmodium falciparum. The research findings provide the basis for future testing in humans to determine ...

A multimodal intervention to reduce one of the most common healthcare-acquired infections

March 16, 2018
Surgical site infections are the most frequent health care-associated infections in developing countries. According to the World Health Organization (WHO), this type of infection can affect up to one-third of surgical patients ...

After infection, herpes lurks in nerve cells, ready to strike—New research reveals what enables the virus to do so

March 15, 2018
Once herpes simplex infects a person, the virus goes into hiding inside nerve cells, hibernating there for life, periodically waking up from its sleep to reignite infection, causing cold sores or genital lesions to recur.

New imaging approach offers unprecedented views of staph infection

March 14, 2018
Eric Skaar, PhD, MPH, marvels at the images on his computer screen—3-D molecular-level views of infection in a mouse. "I'm pretty convinced that these are the most advanced images in infection biology," said Skaar, Ernest ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.